Altamira Therapeutics Ltd. earnings per share and revenue

CYTO earnings per share for the last semiannual are -1.99 USD whereas the estimation was -2.38 USD which accounts for 16.60% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next semiannual are -0.57 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of CYTO earnings per share and revenue dynamics.